These Nanotech Bubbles Burst When They Detect Viruses in the Air
Scientists have shown that they can detect SARS-CoV-2, the virus that causes COVID-19, in the air by using a nanotechnology-packed ...
Tag: SARS-CoV-2
Many Children Hospitalized with COVID-19 or MIS-C Have Lingering Complications Months Later
National follow-up study identifies risk factors for a prolonged recovery In one of the largest follow-up studies to date, involving ...
Children Infected with a Mild Case of COVID-19 Can Still Develop Long COVID Symptoms
While research has revealed that children and adults hospitalized with COVID-19 are more susceptible to developing long COVID symptoms, a ...
Long COVID: National Academies’ Panel Examines Long-Term Health Effects of COVID-19
Long COVID is associated with multisystem dysfunction affecting the cerebrovascular, autonomic, peripheral, respiratory, and inflammatory systems, which may be caused ...
Pathogen Crescendo: Brass, Woodwinds Section Emit Respiratory Particles
Just like coughing, sneezing, talking and singing, playing wind instruments can spread respiratory particles that may carry the COVID-19 virus ...
Adverse Events After Simultaneous COVID-19 mRNA Booster, Flu Vaccination
Are systemic reactions more common after simultaneous administration of COVID-19 mRNA booster and seasonal influenza vaccines than after COVID-19 mRNA ...
How a COVID-19 Infection Spurs Antibodies Against Common Colds
Scientists at Scripps Research analyzing coronavirus antibodies found more antibodies that recognize other, related viruses in people who had been ...
Where is Testing Needed Most During Pandemic Surges? WVU Researchers Develop Machine Learning Prediction Tools
West Virginia University scientists are applying machine learning and geographic data to understand where places with low vaccination rates need ...
We’ll See More ‘Hybrids’ Like Omicron XE as COVID Continues to Evolve
A new hybrid COVID-19 variant dubbed XE has sparked fresh concerns recently. XE is a combination of the highly transmissible ...
Northwestern University Researchers Develop Nanoparticle Vaccine Platform
Nanoparticle-based COVID-19 vaccine could target future infectious diseases Just one dose of a new nanoparticle-based COVID-19 vaccine was enough to ...
Will the BA.2 Subvariant Cause Another Wave of Infections in the US?
A new omicron subvariant of the virus that causes COVID-19, BA.2, is quickly becoming the predominant source of infections amid ...
As New Zealand Relaxes Restrictions, Steps Can Still Be Taken to Limit COVID Infections
New Zealanders are about to enjoy cautiously relaxed COVID restrictions under the country’s COVID-19 Protection Framework, starting from this weekend. ...
Some PASC Patients May Experience Long-Lasting Airway Disease — Even if They Only Had Mild COVID-19
Patients in this study with post-acute sequelae of COVID-19 (PASC), or 'Long Covid', experienced small airway disease independent of initial ...
Neurological Symptoms are Present in Roughly Two-Thirds of Hospitalized COVID-19 Patients
Molecular imaging uncovers effects of COVID-19 on the brain Incidence of dementia, parkinsonism and psychiatric disorders within six months after ...
U.S. Opens Funding for New Public Health Pathogens Genomics Centers of Excellence
The Centers for Disease Control and Prevention (CDC) has announced the availability of cooperative agreement funds for this fiscal year ...
Even Mild or Moderate COVID-19 Illness Affects Cardiovascular System in Young Adults
Researchers followed young men and women aged 20-40 without pre-existing disease. The findings show that obesity and physical inactivity increase ...
Rapid COVID-19 PCR Test Developed at Northwestern Receives FDA Emergency Use Authorization
Northwestern University faculty and spinoff company developed the new technology A new highly sensitive, easy-to-use test for COVID-19 that requires ...
New NIH Study Will Follow Patients That Had Allergic Reaction to mRNA COVID-19 Vaccines
Researchers from the National Institute of Allergy and Infectious Diseases (NIAID) are conducting a clinical trial designed to help understand ...
Antivirals, Some Antibodies, Work Well Against BA.2 Omicron Variant of COVID-19 Virus
The antiviral therapies remdesivir, molnupiravir, and the active ingredient in Pfizer’s Paxlovid pill (nirmatrelvir), remain effective in laboratory tests against ...
Even Mild Cases of COVID-19 Can Leave a Mark on the Brain — Such as Reductions in Gray Matter
Researchers have been steadily gathering important insights into the effects of COVID-19 on the body and brain. Two years into ...
